Navigation Links
Bio-AMD, Inc.: Medical Device Operational Update, Commercial Discussions
Date:9/10/2012

ring tolerance. The Company also believes that, amongst other things, the benefits of our patented quad sensor technology and cartridge cap are attractive to the market.

In the case of COAG we have conducted a study on our proprietary test strips and we are now in informal talks with a prospective partner with a global reach with the intention of reaching a commercial development arrangement. The Company believes that the relative simplicity of the COAG technology and its manufacturing cost advantages are very attractive to the prospective partner. We also believe that the prospective partner recognises that COAG efficiently addresses high demand in a poorly developed market currently served only by relatively expensive and/or problematic devices.

Whilst there can be no guarantee that these discussions surrounding DSR and COAG will lead to acceptable commercial deal(s), the Company is highly encouraged by the level of engagement demonstrated by prospective partners and the stage these discussions have reached. Further announcements will be made as appropriate, in due course.

About DSR

Our DSR technology is a patented method of reading and quantifying traditional chromatography based, lateral-flow immunoassays including pregnancy and fertility testing, cardiac markers, infectious diseases and drug testing.  Compared to existing analog tests DSR offers increased sensitivity and semi-quantitative measurement, allowing earlier diagnostic testing with improved accuracy.

The DSR hand-held reader device design incorporates portability, scalability and repeatability with low manufacturing costs. Our technology also runs on photo-electric power, avoiding the need for chemical batteries and the disposal issues arising from them.

About COAG

COAG is a patented technology that can be incorporated into a hand held device to enable point of care and patient self-testing of blood clotting time. This is especially relevant to pat
'/>"/>

SOURCE Bio-AMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
2. TechPrecision Receives Additional Medical Purchase Orders Exceeding $1.5 Million
3. BiO2 Medical Raises $12M in Series C Funding
4. As Medical Device Sales Jump in Emerging Markets, Organizations Embrace Outsourcing Clinical Activities
5. Federal Appeals Court Upholds Fraud Verdict Against Cornell University Medical School For Misuse Of NIH Aids Funding
6. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
7. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
8. Medical Alarm Retires Last of Convertible Preferred Stock
9. Concord Medical Responds to Unusual Market Activity in its Stock
10. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
11. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Dohmen Company CEO ... for the Metropolitan Milwaukee Association of Commerce,s annual ,Future ... at the Pfister Hotel. The ,Future 50, Awards highlights ... businesses and young firms headquartered in the seven-county ... has called Milwaukee home for ...
(Date:9/4/2015)... , Sept. 4, 2015  Luminex Corporation (NASDAQ: ... the Morgan Stanley Global Healthcare Conference to be held ... Hotel in New York City . ... a.m. Eastern time on Friday, September 18, 2015.  The ... Luminex Corporation,s website at http://www.luminexcorp.com . Simply log on ...
(Date:9/4/2015)... According to a new market ... Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis ... Forecast to 2020", published by MarketsandMarkets, the global Apheresis ... 2020, growing at a CAGR of 11.2% during the ... Browse 139 Tables and 45 F igures spread ...
Breaking Medicine Technology:Dohmen CEO Cynthia LaConte to Keynote MMAC 'Future 50' Awards Luncheon 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5
... NEW YORK, June 2, 2011 Citeline, the world,s ... recently completed a comprehensive review of clinical trial starts ... patterns in drug development. Over the one-year review period ... trials were initiated in the oncology sector, more than ...
... Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today ... Trademark Office of Patent Application Serial No. 12/549458 ... This follows the UK issuance which was granted ... patent estate. The patent covers the ...
Cached Medicine Technology:Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 2Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 3Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety of ... which affects hospitals’ abilities to provide quality service to those with serious needs, increases ... problem has recently presented itself, the new telemedicine platform and app, DocChat . ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
(Date:9/4/2015)... Washington, DC (PRWEB) , ... September 04, 2015 ... ... dollar-wise they all pale in comparison to settlements under the Stark physician self-referral ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... a Labor Day offer that cannot be passed up. FiltersFast.com, will ship ... necessary air and water filtration product replacements. Take advantage of this promotion now ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Friday night, Chicago ... hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, raising ... Rowena and Joe Salas, joined together at the Oscar Swan Inn to support the ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... , , , ... were considered prized possessions of the Emperors of China and were personally ... Monarchs of Europe and discerning people all over the world. This luxurious ... most popular dog breeds today. , , ...
... , KUALA LUMPUR, Malaysia, Aug. 26 ... privatization within the healthcare service provision and upgrading of existing ... services has also received positive impetus from growing promotion of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , According ...
... Health Group Inc. ("AIM" or the "Company") (TSXV - AHG), ... net income for the three month period ended June 30, ... $118,223 in the same period in 2008. At the same ... quarter-over-quarter basis. The Company also announced that revenues increased 102% ...
... is the GlaxoSmithKline statement in response to the FDA,s Early Communication about ... stands firmly behind the safety and efficacy of alli . ... that there is no evidence that alli causes liver damage. ... cases on liver injury associated with the use of orlistat/alli. Any routine ...
... restart production of missing protein , TUESDAY, Aug. 25 ... appears to jump-start the production of a crucial protein ... researchers report. , The treatment so far is only ... debilitating and ultimately fatal disease, but scientists are hopeful ...
... with coronary artery disease-induced congestive heart failure or heart ... radiation therapy for treatment of prostate cancer have an ... in the August 26 issue of JAMA . ... options available for treatment, including the use of brachytherapy ...
Cached Medicine News:Health News:Royal Canin Continues to Pioneer the Pet Food Industry With an Exclusive Diet Just for Pugs 2Health News:Frost & Sullivan: Growing Healthcare Tourism in Malaysia 2Health News:Frost & Sullivan: Growing Healthcare Tourism in Malaysia 3Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 2Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 3Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 4Health News:AIM Health Group Inc. announces June 30, 2009 financial results showing continued improvement in quarterly profits 5Health News:Experimental Treatment Could Fight Muscular Dystrophy 2Health News:Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: